{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:22:12Z","timestamp":1788434532381,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58425-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:56:46Z","timestamp":1781621806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Photodynamic therapy enhances dacarbazine sensitivity of melanoma cells by induction of apoptosis and downregulation of PI3K\/AKT signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Masoumeh","family":"Hajizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Doustvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Mohammadnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Allahyarzadeh","family":"Khiabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima Alizadeh","family":"Nobari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Samaneh Shahriar","family":"Oskouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Tajalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Mehdizadehfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"5_suppl","key":"58425_CR1","doi-asserted-by":"publisher","first-page":"730S","DOI":"10.1177\/0145561320904813","volume":"100","author":"L Li","year":"2021","unstructured":"Li, L., London, N. R. & Chen, X. Malignant mucosal melanoma of the eustachian tube with extension into the ipsilateral external ear canal: a case report and review of the literature. Ear Nose Throat J. 100 (5_suppl), 730S\u2013733S (2021).","journal-title":"Ear Nose Throat J."},{"key":"58425_CR2","doi-asserted-by":"crossref","unstructured":"Yang, B. et al. MiR-5195-3p targets the PCBP2\/PI3K\/AKT pathway to inhibit melanoma cell proliferation and migration. Heliyon 9 (9). (2023).","DOI":"10.1016\/j.heliyon.2023.e19227"},{"key":"58425_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-018-0675-0","volume":"20","author":"SS Yde","year":"2018","unstructured":"Yde, S. S. et al. Mucosal melanoma: a literature review. Curr. Oncol. Rep. 20, 1\u201310 (2018).","journal-title":"Curr. Oncol. Rep."},{"key":"58425_CR4","doi-asserted-by":"crossref","unstructured":"Domingues, B. et al. Melanoma treatment in review. ImmunoTargets Therapy, 35\u201349. (2018).","DOI":"10.2147\/ITT.S134842"},{"issue":"19","key":"58425_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","volume":"377","author":"J Weber","year":"2017","unstructured":"Weber, J. et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N. Engl. J. Med. 377 (19), 1824\u20131835 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"58425_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok, J. D. et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N. Engl. J. Med. 377 (14), 1345\u20131356 (2017).","journal-title":"N. Engl. J. Med."},{"key":"58425_CR7","doi-asserted-by":"publisher","first-page":"113754","DOI":"10.1016\/j.biopha.2022.113754","volume":"156","author":"T Hell","year":"2022","unstructured":"Hell, T. et al. Flavonoids from Ericameria nauseosa inhibiting PI3K\/AKT pathway in human melanoma cells. Biomed. Pharmacother. 156, 113754 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"58425_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40259-016-0208-z","volume":"31","author":"E Simeone","year":"2017","unstructured":"Simeone, E. et al. Combination treatment of patients with BRAF-mutant melanoma: a new standard of care. BioDrugs 31, 51\u201361 (2017).","journal-title":"BioDrugs"},{"issue":"6","key":"58425_CR9","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","volume":"24","author":"TN Gide","year":"2018","unstructured":"Gide, T. N. et al. Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma. Clin. Cancer Res. 24 (6), 1260\u20131270 (2018).","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"58425_CR10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.tranon.2017.09.007","volume":"10","author":"TM Grzywa","year":"2017","unstructured":"Grzywa, T. M., Paskal, W. & W\u0142odarski, P. K. Intratumor and intertumor heterogeneity in melanoma. Translational Oncol. 10 (6), 956\u2013975 (2017).","journal-title":"Translational Oncol."},{"issue":"3","key":"58425_CR11","first-page":"228","volume":"6","author":"Y Liu","year":"2014","unstructured":"Liu, Y. & Sheikh, M. S. Melanoma: molecular pathogenesis and therapeutic management. Mol. Cell. Pharmacol. 6 (3), 228 (2014).","journal-title":"Mol. Cell. Pharmacol."},{"issue":"6","key":"58425_CR12","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.gendis.2022.04.004","volume":"9","author":"W Wagstaff","year":"2022","unstructured":"Wagstaff, W. et al. Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance. Genes Dis. 9 (6), 1608\u20131623 (2022).","journal-title":"Genes Dis."},{"key":"58425_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jphotobiol.2016.11.004","volume":"166","author":"FN Biteghe","year":"2017","unstructured":"Biteghe, F. N. & Davids, L. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells. J. Photochem. Photobiol., B. 166, 18\u201327 (2017).","journal-title":"J. Photochem. Photobiol., B"},{"issue":"1","key":"58425_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10103-026-04849-w","volume":"41","author":"MA Doustvandi","year":"2026","unstructured":"Doustvandi, M. A. et al. Photodynamic therapy with zinc phthalocyanine suppresses immune checkpoints in human melanoma cells. Lasers Med. Sci. 41 (1), 78 (2026).","journal-title":"Lasers Med. Sci."},{"key":"58425_CR15","doi-asserted-by":"crossref","unstructured":"Doustvandi, M. A. et al. Photodynamic therapy reduced stemness and cell migration in triple-negative breast cancer cells through the PTEN\/CD44 signaling pathway: A comparative study. Biochem. Biophys. Res. Commun. 153060 (2025).","DOI":"10.1016\/j.bbrc.2025.153060"},{"key":"58425_CR16","doi-asserted-by":"publisher","first-page":"100685","DOI":"10.1016\/j.pmatsci.2020.100685","volume":"114","author":"JJ Hu","year":"2020","unstructured":"Hu, J. J., Lei, Q. & Zhang, X. Z. Recent advances in photonanomedicines for enhanced cancer photodynamic therapy. Prog. Mater. Sci. 114, 100685 (2020).","journal-title":"Prog. Mater. Sci."},{"issue":"4","key":"58425_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.20114","volume":"61","author":"P Agostinis","year":"2011","unstructured":"Agostinis, P. et al. Photodynamic therapy of cancer: an update. Cancer J. Clin. 61 (4), 250\u2013281 (2011).","journal-title":"Cancer J. Clin."},{"issue":"2","key":"58425_CR18","first-page":"149","volume":"21","author":"A El-Hussein","year":"2021","unstructured":"El-Hussein, A. et al. A review of chemotherapy and photodynamic therapy for lung cancer treatment. Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chemistry-Anti-Cancer Agents). 21 (2), 149\u2013161 (2021).","journal-title":"Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chemistry-Anti-Cancer Agents)"},{"issue":"3","key":"58425_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/cancers15030585","volume":"15","author":"W Jiang","year":"2023","unstructured":"Jiang, W. et al. The current status of photodynamic therapy in cancer treatment. Cancers 15 (3), 585 (2023).","journal-title":"Cancers"},{"issue":"2","key":"58425_CR20","first-page":"109","volume":"63","author":"I Baldea","year":"2012","unstructured":"Baldea, I. & Filip, A. Photodynamic therapy in melanoma\u2014an update. J. Physiol. Pharmacol. 63 (2), 109 (2012).","journal-title":"J. Physiol. Pharmacol."},{"issue":"5","key":"58425_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jid.2021.08.442","volume":"142","author":"S Chilibroste","year":"2022","unstructured":"Chilibroste, S. et al. Preclinical evaluation of LVR01 attenuated salmonella as neoadjuvant intralesional therapy in combination with chemotherapy for melanoma treatment. J. Invest. Dermatology. 142 (5), 1435\u20131443 (2022). e2.","journal-title":"J. Invest. Dermatology"},{"key":"58425_CR22","doi-asserted-by":"crossref","unstructured":"Wilson, M. A. & Schuchter, L. M. Chemotherapy for Melanoma. 209\u2013229. (2016).","DOI":"10.1007\/978-3-319-22539-5_8"},{"issue":"3","key":"58425_CR23","doi-asserted-by":"publisher","first-page":"MMT27","DOI":"10.2217\/mmt-2019-0007","volume":"6","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. The emergence of neoadjuvant therapy in advanced melanoma. Melanoma Manage. 6 (3), MMT27 (2019).","journal-title":"Melanoma Manage."},{"issue":"1","key":"58425_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-021-00827-6","volume":"6","author":"W Guo","year":"2021","unstructured":"Guo, W., Wang, H. & Li, C. Signal pathways of melanoma and targeted therapy. Signal. Transduct. Target. therapy. 6 (1), 424 (2021).","journal-title":"Signal. Transduct. Target. therapy"},{"issue":"19","key":"58425_CR25","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1158\/0008-5472.CAN-04-1399","volume":"64","author":"JM Stahl","year":"2004","unstructured":"Stahl, J. M. et al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res. 64 (19), 7002\u20137010 (2004).","journal-title":"Cancer Res."},{"issue":"4","key":"58425_CR26","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0002-9440(10)64627-5","volume":"157","author":"XP Zhou","year":"2000","unstructured":"Zhou, X. P. et al. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am. J. Pathol. 157 (4), 1123\u20131128 (2000).","journal-title":"Am. J. Pathol."},{"issue":"2","key":"58425_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.canlet.2011.09.037","volume":"314","author":"I S\u00e1nchez-Hern\u00e1ndez","year":"2012","unstructured":"S\u00e1nchez-Hern\u00e1ndez, I. et al. Dual inhibition of V600EBRAF and the PI3K\/AKT\/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism. Cancer Lett. 314 (2), 244\u2013255 (2012).","journal-title":"Cancer Lett."},{"key":"58425_CR28","doi-asserted-by":"publisher","first-page":"111331","DOI":"10.1016\/j.biopha.2021.111331","volume":"137","author":"B Huang","year":"2021","unstructured":"Huang, B. et al. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C\/VEGFR-3 dependent PI3K\/AKT pathway. Biomed. Pharmacother. 137, 111331 (2021).","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"58425_CR29","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3892\/or.2014.3327","volume":"42","author":"H Li","year":"2019","unstructured":"Li, H. et al. Hedyotis diffusa Willd. inhibits VEGF\u2013C\u2013mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways. Oncol. Rep. 42 (3), 1225\u20131236 (2019).","journal-title":"Oncol. Rep."},{"issue":"4","key":"58425_CR30","first-page":"580","volume":"40","author":"K Tang","year":"2020","unstructured":"Tang, K. et al. Effect of honokiol on proliferation, migration and apoptosis of human tongue cancer CAL-27 cells in vitro. Nan Fang yi ke da xue xue bao=. J. South. Med. Univ. 40 (4), 580\u2013585 (2020).","journal-title":"J. South. Med. Univ."},{"issue":"22","key":"58425_CR31","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1158\/0008-5472.CAN-11-1338","volume":"71","author":"YA Yoo","year":"2011","unstructured":"Yoo, Y. A. et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res. 71 (22), 7061\u20137070 (2011).","journal-title":"Cancer Res."},{"key":"58425_CR32","doi-asserted-by":"publisher","first-page":"112014","DOI":"10.1016\/j.msec.2021.112014","volume":"123","author":"X Zhan","year":"2021","unstructured":"Zhan, X. et al. CD47-mediated DTIC-loaded chitosan oligosaccharide-grafted nGO for synergistic chemo-photothermal therapy against malignant melanoma. Mater. Sci. Engineering: C. 123, 112014 (2021).","journal-title":"Mater. Sci. Engineering: C"},{"key":"58425_CR33","doi-asserted-by":"publisher","first-page":"103212","DOI":"10.1016\/j.pdpdt.2022.103212","volume":"41","author":"N Rajabi","year":"2023","unstructured":"Rajabi, N. et al. Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer? Photodiagn. Photodyn. Ther. 41, 103212 (2023).","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"58425_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pdpdt.2019.08.027","volume":"28","author":"MA Doustvandi","year":"2019","unstructured":"Doustvandi, M. A. et al. Photodynamic therapy using zinc phthalocyanine with low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells. Photodiagn. Photodyn. Ther. 28, 88\u201397 (2019).","journal-title":"Photodiagn. Photodyn. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58425-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58425-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58425-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:05:32Z","timestamp":1788433532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58425-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58425"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58425-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was ethically wise accepted by the ethics committee of Tabriz University of Medical Sciences, Tabriz, Iran (IR.TBZMED.VCR.REC.1401.230).","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27588"}}